{
  "meta": {
    "title": "Neurodegenerative_Diseases",
    "url": "https://brainandscalpel.vercel.app/neurodegenerative-diseases-b1bc1c5b.html",
    "scrapedAt": "2025-11-29T18:33:51.719Z"
  },
  "questions": [
    {
      "id": 14603,
      "choices": [
        {
          "id": 58373,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Felbamate</span></span></p>"
        },
        {
          "id": 58374,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methadone </span></span></p>"
        },
        {
          "id": 58375,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ketamine </span></span></p>"
        },
        {
          "id": 58376,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diltiazem </span></span></p>"
        }
      ],
      "text": "<p style=\"margin-left:0; margin-right:0; text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">All the following drugs are NMDA receptor blockers except.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>",
      "unique_key": "Q8776061",
      "question_audio": null,
      "question_video": null,
      "map_id": 36181,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Diltiazem </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>N-methyl-D-aspartate (NMDA) receptors</strong> are <strong>ionotropic glutamate receptors</strong> found in the <strong>central nervous system (CNS).</strong> These <strong>receptors</strong> are involved in <strong>synaptic plasticity</strong>, which is the process by which<strong> neurons adapt</strong> and <strong>change their strength in response</strong> to <strong>stimuli, </strong>including<strong> learning and memory. </strong>The activation of <strong>NMDA receptors </strong>requires<strong> both glutamate and glycine or D-serine,</strong> as well as the removal of a <strong>magnesium ion </strong>that<strong> blocks the channel at resting membrane potentials.</strong> The<strong> influx of calcium ions</strong> through the <strong>open channel</strong> leads to the<strong> activation of various intracellular signalling pathways</strong>, which can have<strong> both beneficial and detrimental effects on neuronal function.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>NMDA receptor blockers</strong> are drugs that<strong> inhibit the activity of NMDA receptors</strong>. They can be classified as either<strong> competitive or non-competitive antagonists, </strong>depending on the <strong>mechanism of action</strong>. <strong>Competitive antagonists </strong>bind to the<strong> same site as the agonist,</strong> whereas <strong>non-competitive antagonists bind </strong>to a <strong>separate site on the receptor.</strong> <strong>Clinically useful drugs</strong> are all <strong>non-competitive NMDA</strong> <strong>antagonists.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">IMPORTANT NDMA RECEPTOR ANTAGONISTS:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">F</span></strong><span style=\"font-size:12.0pt\">inal:&nbsp;&nbsp; <strong>F</strong>elbamate, <strong>P</strong>hencyclidine</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">N</span></strong><span style=\"font-size:12.0pt\">: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>N</strong>itrous oxide</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">M</span></strong><span style=\"font-size:12.0pt\">:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>M</strong>ethadone, <strong>M</strong>emantine, <strong>M</strong>agnesium</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">D</span></strong><span style=\"font-size:12.0pt\">:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>D</strong>extromethorphan</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">A</span></strong><span style=\"font-size:12.0pt\">:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>A</strong>camprosate, <strong>A</strong>mantadine</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">R</span></strong><span style=\"font-size:12.0pt\">eceptor:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>R</strong>iluzole</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">K</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">nockout:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>K</strong>etamine and Es<strong>k</strong>etamine</span></span></p>",
      "correct_choice_id": 58376,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14499,
      "choices": [
        {
          "id": 57957,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Flumazenil</span></span></span></p>"
        },
        {
          "id": 57958,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Disulfiram</span></span></span></p>"
        },
        {
          "id": 57959,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Acamprosate </span></span></span></p>"
        },
        {
          "id": 57960,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Naltrexone</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following drugs is not used in detoxification of patients with chronic alcohol use? </span></span></span></p>",
      "unique_key": "Q6071852",
      "question_audio": null,
      "question_video": null,
      "map_id": 36177,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Flumazenil</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Flumazenil</strong> is an <strong>antagonist</strong> for<strong> benzodiazepine receptors </strong>and is primarily used to <strong>reverse the effects</strong> of <strong>benzodiazepines </strong>in cases of <strong>overdose</strong> or to<strong> hasten recovery after anesthesia</strong>. It <strong>does not</strong> have any role in the<strong> treatment or detoxification process </strong>for<strong> alcohol</strong> <strong>dependency</strong>. Its use is <strong>specific</strong> to the<strong> management of benzodiazepine-related emergencies.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Disulfiram:</span></strong><span style=\"font-size:12.0pt\"> Used as<strong> part of alcohol aversion therapy</strong>, <strong>disulfiram inhibits the enzyme acetaldehyde dehydrogenase,</strong> which leads to <strong>unpleasant effects</strong> when <strong>alcohol is consumed, </strong>thereby <strong>deterring</strong> the <strong>intake of alcohol.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Acamprosate:</span></strong><span style=\"font-size:12.0pt\"> Helps <strong>reduce</strong> the<strong> craving and relapse</strong> in <strong>alcohol dependence </strong>by<strong> modulating neurotransmission </strong>via <strong>glutamate and GABA pathways.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Naltrexone:</span></strong><span style=\"font-size:12.0pt\"> Used as an<strong> anti-craving agent,</strong> <strong>naltrexone blocks opioid receptors</strong> that are part of the <strong>reward system</strong> affected by<strong> alcohol consumption.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">While<strong> disulfiram, acamprosate, and naltrexone </strong>are <strong>directly</strong> involved in the <strong>treatment strategies for alcohol dependence </strong>to prevent <strong>relapse and manage cravings</strong>, <strong>flumazenil&#39;s </strong>application is<strong> restricted to benzodiazepine reversal,</strong> underscoring the<strong> </strong>importance of understanding<strong> specific drug roles in addiction therapy.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Drugs Used in Acute Ethanol Withdrawal </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Benzodiazepines</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> (chlordiazepoxide, diazepam, lorazepam): They facilitate<strong> GABA-mediated activation of GABA receptors. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thiamine</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> (vitamin B1): <strong>Alcoholic patients</strong> are <strong>deficient in thiamine.</strong> Hence, it must be <strong>administered to patients </strong>suspected of having <strong>alcoholism</strong> (those<strong> exhibiting acute alcohol intoxication or alcohol withdrawal syndrome</strong>) to <strong>prevent Wernicke-Korsakoff syndrome. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Drugs Used in Chronic Alcoholism (Alcohol dependence)</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Naltrexone</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">:<strong> Competitive antagonist </strong>of<strong> opioid receptors</strong>. It <strong>reduces</strong> <strong>craving </strong>in alcoholics.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acamprosate</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: <strong>NMDA receptor antagonist &amp; GABAA agonist </strong>effects. It also <strong>reduces craving.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Topiramate</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This <strong>anticonvulsant drug </strong>is also<strong> effective in reducing craving</strong>. It potentiates the <strong>inhibitory effects of GABA</strong> but <strong>acts at</strong> a <strong>site different from BZD.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Disulfiram</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: It is an<strong> inhibitor of aldehyde dehydrogenase</strong> and therefore <strong>causes accumulation of aldehyde </strong>if <strong>alcohol is ingested. </strong>This results in<strong> troublesome symptoms</strong>, like<strong> facial flushing, nausea, dizziness, headache.</strong> It is used as a <strong>deterrent agent (aversion therapy)</strong> to<strong> reduce the consumption of alcohol</strong> in motivated individuals. </span></span></p>",
      "correct_choice_id": 57957,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14620,
      "choices": [
        {
          "id": 58441,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Migraine</span></span></p>"
        },
        {
          "id": 58442,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lennox Gastaut syndrome</span></span></p>"
        },
        {
          "id": 58443,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Attention Deficit Hyperactivity Disorder</span></span></p>"
        },
        {
          "id": 58444,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dementia</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Topiramate is used in the treatment of?</span></span></span></p>",
      "unique_key": "Q7232425",
      "question_audio": null,
      "question_video": null,
      "map_id": 36189,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Ans. B) Lennox Gastaut syndrome.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><strong>Topiramate</strong> is a medication with<strong> multiple indications.</strong> Let&#39;s evaluate each of the options provided:</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><strong>&nbsp;Lennox-Gastaut syndrome</strong>: This is a<strong> correct indication </strong>for <strong>topiramate.</strong> It is one of the <strong>medications</strong> that can be<strong> used to</strong> manage <strong>seizures associated with Lennox-Gastaut syndrome,</strong> which is a <strong>severe form of childhood-onset epilepsy</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Migraine</strong>:<strong> Topiramate</strong> is used as a<strong> prophylactic agent for migraine</strong>. It&#39;s <strong>not </strong>used to treat an <strong>acute attack of migraine </strong>but rather to <strong>decrease the frequency, severity, and duration of migraine headaches </strong>when<strong> taken regularly.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Attention Deficit Hyperactivity Disorder (ADHD</strong>): <strong>Topiramate</strong> is <strong>not </strong>a <strong>standard</strong> treatment for <strong>ADHD</strong>. The primary treatments for<strong> ADHD are stimulant medications</strong>, such as <strong>methylphenidate and amphetamines,</strong> as well as certain <strong>non-stimulant medications.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Dementia</strong>: <strong>Topiramate</strong> is <strong>not</strong> indicated for the treatment of <strong>dementia</strong>. <strong>Treatments</strong> for<strong> dementia</strong> typically include<strong> cholinesterase inhibitors and memantine</strong>, which are aimed at <strong>improving cognitive symptoms</strong> or <strong>slowing their progression.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">NON-ANTIEPILEPTIC USES OF TOPIRAMATE:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/10/screenshot-2024-05-10-182151.jpg\" style=\"height:590px; width:1000px\" /></span></span></u></strong></p>",
      "correct_choice_id": 58442,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14604,
      "choices": [
        {
          "id": 58377,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cefixime</span></span></span></p>"
        },
        {
          "id": 58378,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cefoperazone</span></span></span></p>"
        },
        {
          "id": 58379,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chlorpropamide</span></span></span></p>"
        },
        {
          "id": 58380,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Metronidazole</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Patients should be cautioned not to consume alcohol when given a prescription for any of the following EXCEPT? </span></span></p>",
      "unique_key": "Q2814714",
      "question_audio": null,
      "question_video": null,
      "map_id": 36182,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Cefixime</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Disulfiram-like reaction</strong> is characterized by symptoms such as <strong>flushing, headache, nausea, vomiting, palpitations, and hypotension,</strong> which occur<strong> due to inhibition of aldehyde dehydrogenase</strong> and <strong>accumulation of acetaldehyde in the body.</strong> </span><span style=\"font-size:12.0pt\"><strong>Cefixime</strong> is a <strong>third-generation cephalosporin</strong> <strong>antibiotic</strong> that is<strong> used to treat</strong> a variety of <strong>bacterial infections.</strong> <strong>Unlike </strong>some other <strong>cephalosporins, </strong>such as <strong>cefoperazone, cefixime does not</strong> have a significant <strong>disulfiram-like interaction with alcohol. </strong>Therefore, p<strong>atients taking cefixime</strong> are <strong>not </strong>specifically <strong>cautioned against consuming alcohol </strong>due to a <strong>risk of adverse reactions</strong>, though <strong>moderation </strong>is generally <strong>advisable</strong> <strong>with any medication.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Cefoperazone:</span></strong><span style=\"font-size:12.0pt\"> Cefoperazone, a <strong>cephalosporin antibiotic,</strong> is known to cause a<strong> disulfiram-like reaction with alcohol, </strong>which can lead to symptoms like <strong>flushing, nausea, vomiting, and tachycardia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Chlorpropamide:</span></strong><span style=\"font-size:12.0pt\"> Chlorpropamide, a<strong> sulfonylurea </strong>used in the treatment of<strong> type 2 diabetes</strong>, can also cause a <strong>disulfiram-like</strong> reaction with <strong>alcohol, </strong>leading to <strong>unpleasant symptoms.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Metronidazole:</span></strong><span style=\"font-size:12.0pt\"> Metronidazole, an <strong>antibiotic</strong> used for various<strong> bacterial and protozoal infections</strong>, is well-known for causing <strong>severe disulfiram</strong>-like reactions with alcohol, including <strong>nausea, vomiting, headache, and flushing.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The educational objective is to<strong> know</strong> the drugs causing <strong>disulfiram like reaction with alcohol. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">DRUGS SHOWING DISULFIRAM LIKE REACTION WITH ALCOHOL:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/10/screenshot-2024-05-10-175109.jpg\" style=\"height:837px; width:1000px\" /></span></strong></span></span></p>",
      "correct_choice_id": 58377,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14473,
      "choices": [
        {
          "id": 57853,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Retigabine</span></span></span></p>"
        },
        {
          "id": 57854,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lamotrigine</span></span></span></p>"
        },
        {
          "id": 57855,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Levetiracetam</span></span></span></p>"
        },
        {
          "id": 57856,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Topiramate</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Drug E in the image shown is likely to be?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/10/picture4.jpg\" style=\"height:185px; width:400px\" /></span></span></span></p>",
      "unique_key": "Q5498655",
      "question_audio": null,
      "question_video": null,
      "map_id": 36180,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Retigabine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Retigabine</strong>, also known as<strong> ezogabine,</strong> is an <strong>antiepileptic drug</strong> primarily used as an<strong> adjunctive treatment for focal seizures.</strong> It is unique among <strong>antiepileptic drugs</strong> because<strong> it functions as a neuronal potassium channel opener</strong>. This <strong>mechanism of action helps</strong> <strong>stabilize neuronal membranes</strong> and <strong>reduces excitability, </strong>which <strong>can prevent</strong> the <strong>occurrence of seizures.</strong> <strong>Retigabine</strong> is <strong>distinct </strong>in its <strong>class </strong>due to this<strong> unusual method </strong>of<strong> influencing neuronal activity.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Lamotrigine:</span></strong><span style=\"font-size:12.0pt\"> Works by<strong> blocking voltage-gated sodium channels</strong> and <strong>diminishing glutamate</strong> release but <strong>does not </strong>act as a <strong>potassium channel opener.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Levetiracetam:</span></strong><span style=\"font-size:12.0pt\"> Has a unique mechanism involving the <strong>modulation of neurotransmitter release</strong> through <strong>binding to the</strong> <strong>synaptic vesicle protein SV2A.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Topiramate:</span></strong><span style=\"font-size:12.0pt\"> Acts through <strong>multiple mechanisms</strong>, including<strong> blocking voltage-dependent sodium channels</strong> and <strong>enhancing</strong> <strong>GABA activity, </strong>but<strong> not </strong>specifically through <strong>opening potassium channels.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Retigabine</strong> is notable for<strong> its mechanism as a neuronal potassium channel opener, </strong>a <strong>distinct mode of action </strong>that differentiates it from other antiepileptic drugs. <strong>Major adverse effects</strong> to be aware of with<strong> retigabine include retinitis and blue pigmentation of the skin.</strong></span></span></p>",
      "correct_choice_id": 57853,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14599,
      "choices": [
        {
          "id": 58357,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">SNRI</span></span></span></p>"
        },
        {
          "id": 58358,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">NDRI</span></span></span></p>"
        },
        {
          "id": 58359,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Antihistaminic</span></span></span></p>"
        },
        {
          "id": 58360,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anticholinergic</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tramadol acts on &micro; receptor as an agonist. Additionally, it also acts as: </span></span></span></p>",
      "unique_key": "Q9336520",
      "question_audio": null,
      "question_video": null,
      "map_id": 36178,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) SNRI</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In addition to acting as <strong>an agonist at the &micro;-opioid receptor, tramadol </strong>also has <strong>activity</strong> as a<strong> serotonin-norepinephrine</strong> <strong>reuptake inhibitor (SNRI). </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This <strong>dual mechanism of action</strong> provides <strong>analgesic effects</strong> beyond those <strong>produced by opioids alone. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Tramadol </strong>is <strong>not</strong> an <strong>NDRI (norepinephrine-dopamine reuptake inhibitor), antihistaminic, or anticholinergic.</strong></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 58357,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14568,
      "choices": [
        {
          "id": 58233,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Levodopa</span></span></span></p>"
        },
        {
          "id": 58234,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Amantadine</span></span></span></p>"
        },
        {
          "id": 58235,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Trihexyphenidyl</span></span></span></p>"
        },
        {
          "id": 58236,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Selegiline</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A patient with Parkinsonism developed this condition after treatment. Which of the following agents could be the causative agent?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/10/picture5.jpg\" style=\"height:134px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>",
      "unique_key": "Q5797993",
      "question_audio": null,
      "question_video": null,
      "map_id": 36179,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Amantadine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The <strong>image</strong> provided appears to show a patient with <strong>marked purplish discoloration and swelling in the lower extremities, </strong>which could be consistent with<strong> livedo reticularis,</strong> a condition known to be a<strong> potential side effect</strong> of some medications like <strong>amantadine.</strong> </span><strong><span style=\"font-size:12.0pt\">Amantadine</span></strong><span style=\"font-size:12.0pt\"> is an <strong>antiviral medication</strong> that is also used in the <strong>treatment of Parkinson&#39;s disease.</strong> One of the<strong> known side effects </strong>of amantadine is <strong>livedo reticularis,</strong> a<strong> mottled discoloration of the skin</strong> that is often <strong>purplish and reticular (net-like)</strong>. This <strong>side effect</strong> can be<strong> reversible</strong> upon<strong> discontinuation of the drug.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Levodopa</span></strong><span style=\"font-size:12.0pt\">: While levodopa is the<strong> most effective</strong> medication for the management of<strong> Parkinson&#39;s disease symptoms,</strong> it is <strong>not </strong>commonly associated with <strong>skin changes</strong> like those <strong>depicted in the image.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Trihexyphenidyl</span></strong><span style=\"font-size:12.0pt\">: An<strong> anticholinergic drug</strong> used to<strong> treat Parkinsonism, </strong>but it is <strong>not </strong>typically <strong>linked with the skin condition</strong> <strong>shown.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. &nbsp;Selegiline</span></strong><span style=\"font-size:12.0pt\">: An <strong>MAO-B inhibitor </strong>used to help control the <strong>symptoms of Parkinson&#39;s disease</strong>. It also <strong>does not</strong> commonly cause the <strong>skin changes seen in the image</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The educational goal is to recognize the <strong>side effects</strong> associated with <strong>medications </strong>used in the <strong>treatment of Parkinson&#39;s disease</strong>. <strong>Amantadine </strong>can <strong>cause livedo reticularis</strong>, which is characterized by a<strong> purplish, mottled skin discoloration.</strong></span></span></span></p>",
      "correct_choice_id": 58234,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14450,
      "choices": [
        {
          "id": 57761,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Varenicline</span></span></span></p>"
        },
        {
          "id": 57762,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bupropion</span></span></span></p>"
        },
        {
          "id": 57763,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nicotine chewing gum.</span></span></span></p>"
        },
        {
          "id": 57764,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">All the above</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following drug is used in cigarette smoking cessation?</span></span></span></p>",
      "unique_key": "Q6652929",
      "question_audio": null,
      "question_video": null,
      "map_id": 36186,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) All the above</span></strong>&nbsp;</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">All the options listed (<strong>A: Varenicline, B: Bupropion, C: Nicotine chewing gum</strong>) are <strong>utilized </strong>for <strong>smoking cessation,</strong> <strong>each</strong> operating through <strong>distinct mechanisms:</strong></span></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Varenicline:</span></strong><span style=\"font-size:12.0pt\"> Acts as <strong>a partial agonist at nicotinic receptors</strong> in the brain. It reduces <strong>cravings and withdrawal symptoms</strong> and <strong>blocks </strong>the<strong> rewarding effects of smoking.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Bupropion:</span></strong><span style=\"font-size:12.0pt\"> This <strong>antidepressant aids smoking cessation,</strong> likely by<strong> modulating neurotransmitters like dopamine</strong> and <strong>norepinephrine</strong>, though its exact<strong> mechanism in smoking cessation</strong> <strong>isn&#39;t fully understood.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Nicotine chewing gum:</span></strong><span style=\"font-size:12.0pt\"> Provides <strong>nicotine replacement therapy </strong>by <strong>delivering controlled nicotine doses,</strong> which <strong>helps</strong> <strong>manage withdrawal symptoms</strong> and <strong>reduce smoking urges.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Varenicline:</span></strong><span style=\"font-size:12.0pt\"> <strong>Correct</strong> in<strong> aiding smoking cessation </strong>but <strong>not </strong>the only option.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Bupropion:</span></strong><span style=\"font-size:12.0pt\"> <strong>Correct</strong> but is<strong> one among</strong> several<strong> options.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Nicotine chewing gum:</span></strong><span style=\"font-size:12.0pt\"> Also <strong>correct</strong>, functions as <strong>part of nicotine replacement therapy.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Several pharmacological options</strong> are available for <strong>smoking cessation</strong>, as discussed below </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/10/screenshot-2024-05-10-135415.jpg\" style=\"height:469px; width:1000px\" /></p>",
      "correct_choice_id": 57764,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14560,
      "choices": [
        {
          "id": 58201,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Diazepam </span></span></span></p>"
        },
        {
          "id": 58202,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Lorazepam </span></span></span></p>"
        },
        {
          "id": 58203,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Phenytoin </span></span></span></p>"
        },
        {
          "id": 58204,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sodium valproate</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 25-year-old female patient with a history of epilepsy presents to the emergency room with a prolonged seizure. According to her relatives, she has been experiencing convulsions for over 10 minutes. Which of the following is the drug of choice for the treatment of status epilepticus in this patient?</span></span></span></p>",
      "unique_key": "Q8379190",
      "question_audio": null,
      "question_video": null,
      "map_id": 36174,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Lorazepam</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Status epilepticus </strong>is a <strong>medical emergency </strong>that<strong> requires prompt </strong>treatment to<strong> prevent neurological damage </strong>and other<strong> complications.</strong> The<strong> first-line treatment </strong>for <strong>status epilepticus</strong> is usually a benzodiazepine such as<strong> lorazepam, </strong>which can help to <strong>rapidly terminate the seizure activity.</strong> Lorazepam has a<strong> longer duration of action </strong>compared to diazepam and is <strong>less likely</strong> to cause <strong>respiratory depression.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">If the<strong> seizure continues despite benzodiazepine treatment, </strong>the next step is typically to administer a second-line antiepileptic medication, such as phenytoin or Fosphenytoin.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/10/screenshot-2024-05-10-162643.jpg\" style=\"height:793px; width:1000px\" /></span></span></span></p>",
      "correct_choice_id": 58202,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14580,
      "choices": [
        {
          "id": 58281,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phenytoin</span></span></p>"
        },
        {
          "id": 58282,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Carbamazepine</span></span></span></p>"
        },
        {
          "id": 58283,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Valproate</span></span></span></p>"
        },
        {
          "id": 58284,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ethosuximide</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 30-year-old woman with a history of epilepsy has been on antiepileptic medication for several years. She presents to the clinic with concerns about excessive hair growth on her face and body, which has been progressively increasing in density over the past year. Her medical history is otherwise unremarkable, and she is not on any other medications. Which of the following antiepileptic drugs, if it is part of her treatment regimen, is known to cause hirsutism and could be responsible for the excessive hair growth in this patient?</span></span></span></p>",
      "unique_key": "Q9650503",
      "question_audio": null,
      "question_video": null,
      "map_id": 36187,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Phenytoin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Phenytoin</span></strong><span style=\"font-size:12.0pt\"> is known to cause hirsutism as a side effect. Hirsutism refers to excessive, unwanted hair growth in women in areas where men typically grow hair, such as the face and back. Phenytoin can stimulate hair growth due to its effects on the hair follicles, and this side effect can be distressing to patients.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Carbamazepine</span></strong><span style=\"font-size:12.0pt\">: While carbamazepine has various side effects, hirsutism is not commonly reported with its use.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Valproate</span></strong><span style=\"font-size:12.0pt\">: Valproate is associated with several side effects, including weight gain and hair loss or changes in hair texture, but not typically with hirsutism.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Ethosuximide</span></strong><span style=\"font-size:12.0pt\">: Ethosuximide is used primarily for absence seizures and is not commonly associated with hirsutism as a side effect.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The educational goal is to identify the side effects associated with antiepileptic drugs, particularly phenytoin, which can cause hirsutism. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Important drugs associated with hirsutism are:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">P:&nbsp; P</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">henytoin</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C:&nbsp; C</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">yclosporine</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">M:&nbsp; M</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">inoxidil</span></span></span></p>",
      "correct_choice_id": 58281,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14616,
      "choices": [
        {
          "id": 58425,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pramipexole </span></span></span></p>"
        },
        {
          "id": 58426,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gabapentin</span></span></span></p>"
        },
        {
          "id": 58427,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Iron supplementation </span></span></span></p>"
        },
        {
          "id": 58428,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vit B12</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A young patient presents to OPD with complaints of crawling sensation under his skin on legs. This feeling is relieved as soon as he starts moving his legs. What is the appropriate treatment for him? </span></span></span></p>",
      "unique_key": "Q9614506",
      "question_audio": null,
      "question_video": null,
      "map_id": 36188,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Gabapentin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The<strong> patient&#39;s symptoms</strong> of<strong> crawling sensation</strong> under the<strong> skin in the legs </strong>that is <strong>relieved by movement</strong> are <strong>suggestive of restless legs syndrome (RLS).</strong> <strong>Gabapentin </strong>is<strong> DOC</strong> for <strong>restless leg syndrome </strong>according to latest guidelines.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Other Options:</span></span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Option A. Pramipexole</strong> is a <strong>dopamine agonist</strong> that is<strong> effective</strong> in the <strong>treatment of restless</strong> <strong>legs syndrome</strong>. It works by <strong>increasing dopamine levels in the brain,</strong> which <strong>helps</strong> <strong>alleviate the unpleasant sensations</strong> and the<strong> urge to move the legs.</strong> It was considered <strong>DOC for restless leg syndrome previously</strong>, but <strong>gabapentin</strong> is preferred now due to<strong> its better safety profile.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option C. Iron supplementation</strong> could be <strong>beneficia</strong>l if the patient has <strong>iron deficiency</strong> <strong>anaemia</strong>.</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option D. vitamin B12&nbsp; supplementation&nbsp;</strong>&nbsp;may be<strong> helpful </strong>if there is a<strong> vit-B12&nbsp;&nbsp;deficiency. </strong></span></span></p>",
      "correct_choice_id": 58426,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14464,
      "choices": [
        {
          "id": 57817,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fentanyl</span></span></span></p>"
        },
        {
          "id": 57818,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Morphine</span></span></span></p>"
        },
        {
          "id": 57819,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Codeine</span></span></span></p>"
        },
        {
          "id": 57820,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Oxycodone</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mr. Raj Kumar, a 60-year-old male, has been diagnosed with terminal pancreatic cancer and is experiencing severe pain that is not adequately controlled with oral medications. His physician wants to switch him to a transdermal opioid for more consistent pain control. Which of the following opioids would be the best choice for this patient&rsquo;s malignancy-associated pain?</span></span></span></p>",
      "unique_key": "Q8903345",
      "question_audio": null,
      "question_video": null,
      "map_id": 36175,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.&nbsp;A) Fentanyl </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Fentanyl </strong>is a <strong>highly potent synthetic opioid </strong>ideal for the management of <strong>severe chronic pain</strong>, especially in <strong>cancer patients,</strong> due to its <strong>high lipophilicity </strong>which allows it to be <strong>effectively administered via a transdermal patch</strong>. This <strong>route</strong> provides <strong>consistent</strong> and <strong>sustained analgesia over 72 hours or more</strong>, crucial for patients<strong> requiring stable pain control.</strong> <strong>Fentanyl&rsquo;s effectiveness and ease</strong> of use via<strong> transdermal systems </strong>make it<strong> superior </strong>in this context <strong>compared to other opioids</strong> that are typically <strong>administered orally or by</strong> <strong>injection.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Morphine:</span></strong><span style=\"font-size:12.0pt\"> While effective for <strong>pain management, </strong>it is usually<strong> administered orally or intravenously </strong>and <strong>not commonly</strong> used <strong>transdermally.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Codeine:</span></strong><span style=\"font-size:12.0pt\"><strong> Less potent</strong> than fentanyl and generally used for <strong>milder pain.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Oxycodone:</span></strong><span style=\"font-size:12.0pt\"> Also<strong> effective for pain </strong>control but <strong>lacks the transdermal formulation</strong> that would provide the<strong> continuous</strong> <strong>delivery </strong>needed for this patient&rsquo;s condition.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Fentanyl transdermal patches</strong> are particularly <strong>suited for continuous</strong>, <strong>long-term pain management</strong> in patients with <strong>severe</strong> <strong>malignancy-associated pain, </strong>offering a <strong>practical and effective </strong>option for <strong>maintaining consistent analgesic levels.</strong></span></span></p>",
      "correct_choice_id": 57817,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14607,
      "choices": [
        {
          "id": 58389,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Binding to a specific synaptic protein labelled &#39;SV2A&#39;.</span></span></span></p>"
        },
        {
          "id": 58390,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Inhibitor of GABA transporter GAT-1 </span></span></span></p>"
        },
        {
          "id": 58391,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Inhibitor of GABA transaminase </span></span></span></p>"
        },
        {
          "id": 58392,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">CRMP-2 inhibitor</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 35-year-old male presents with a history of recurrent seizures that have been unresponsive to first-line antiepileptic medications. His neurologist is considering adding levetiracetam as a part of his treatment plan. Which of the following best describes the mechanism of action of levetiracetam in controlling seizures?</span></span></span></p>",
      "unique_key": "Q2542630",
      "question_audio": null,
      "question_video": null,
      "map_id": 36185,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Binding to a specific synaptic protein labelled &#39;SV2A&#39;.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Levetiracetam </strong>is an <strong>antiepileptic drug</strong> that has a unique<strong> mechanism of action</strong> compared to other antiepileptic medications. The options provided describe<strong> different mechanisms</strong> related to <strong>seizure control:</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Binding to a specific synaptic protein labelled &#39;SV2A&#39;</strong>: <strong>Levetiracetam</strong> <strong>binds</strong> to a <strong>synaptic vesicle glycoprotein</strong> called <strong>SV2A.</strong> This <strong>interaction</strong> is believed to<strong> modulate neurotransmitter release,</strong> particularly<strong> reducing the excessive release </strong>of <strong>excitatory neurotransmitters </strong>like <strong>glutamate,</strong> thus<strong> reducing seizure activity.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Inhibitor of GABA transporter GAT-1</span></strong><span style=\"font-size:12.0pt\">: I<strong>nhibition of GAT-1</strong> would <strong>increase</strong> the availability of <strong>GABA,</strong> an <strong>inhibitory</strong> <strong>neurotransmitter</strong>, in the <strong>synaptic cleft.</strong> This mechanism is<strong> not </strong>the <strong>primary mode of action</strong> for<strong> levetiracetam, </strong>but it is the primary <strong>mechanism of action</strong> for <strong>other antiepileptic drugs</strong>, such as<strong> tiagabine.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Inhibitor of GABA transaminase:</span></strong><span style=\"font-size:12.0pt\"> <strong>Inhibition of GABA transaminase </strong>would<strong> prevent</strong> the breakdown of<strong> GABA,</strong> thereby <strong>increasing its concentration </strong>and enhancing its<strong> inhibitory effects.</strong> This mechanism is <strong>not</strong> the primary <strong>mode of action </strong>for <strong>levetiracetam but</strong> is the <strong>primary mechanism</strong> <strong>of action </strong>for drugs like <strong>vigabatrin.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. CRMP-2 inhibitor:</span></strong><span style=\"font-size:12.0pt\"> <strong>Collapsin response mediator protein 2 (CRMP-2)</strong></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong> </strong>is a <strong>protein</strong> involved in <strong>neuronal development </strong>and <strong>axonal growth</strong>. <strong>Lacosamide,</strong> an<strong> antiepileptic drug,</strong> is indeed thought to <strong>interact with collapsin response mediator protein 2 </strong>(<strong>CRMP</strong>-2). This interaction is believed to <strong>stabilize hyperexcitable neuronal membranes</strong>, thus <strong>reducing seizure activity</strong>.<strong> Lacosamide</strong> also enhances the <strong>slow inactivation of voltage-gated sodium channels</strong>, contributing to its <strong>antiepileptic effects.</strong></span></span></span></p>",
      "correct_choice_id": 58389,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14466,
      "choices": [
        {
          "id": 57825,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Flumazenil should be administered intramuscularly for rapid onset of action. </span></span></span></p>"
        },
        {
          "id": 57826,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Flumazenil should be used as a first-line treatment for all cases of benzodiazepine overdose. </span></span></span></p>"
        },
        {
          "id": 57827,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Flumazenil may precipitate seizures in patients with a history of benzodiazepine dependence or withdrawal. </span></span></span></p>"
        },
        {
          "id": 57828,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Flumazenil is not effective in reversing the respiratory depression caused by benzodiazepine overdose.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mr. Chetan, a 35-year-old male, is brought to the emergency department with a suspected drug overdose. He is unresponsive and has shallow breathing. His medical history indicates that he has a history of benzodiazepine abuse. Which of the following statements is true regarding the use of flumazenil in this patient? </span></span></span></p>",
      "unique_key": "Q6798747",
      "question_audio": null,
      "question_video": null,
      "map_id": 36176,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Flumazenil may precipitate seizures in patients with a history of benzodiazepine dependence or withdrawal.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Flumazenil</strong> is a <strong>benzodiazepine receptor antagonist</strong> used as an <strong>antidote</strong> in cases of <strong>benzodiazepine overdose.</strong> It can effectively <strong>reverse</strong> the c<strong>entral depressant effects of benzodiazepines,</strong> including <strong>sedation and respiratory depression</strong>, potentially<strong> restoring</strong> <strong>normal breathing and consciousness</strong>. However, its<strong> use carries the risk of precipitating seizures</strong>, particularly in individuals<strong> with long-term benzodiazepine use </strong>due to the <strong>sudden withdrawal effec</strong>t it <strong>can induce</strong>. This <strong>risk</strong> is significant in patients with a<strong> history of</strong> <strong>benzodiazepine dependence</strong> or those who have used these <strong>drugs to control seizure disorders.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Flumazenil should be administered intramuscularly for rapid onset of action:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect,</strong> as <strong>flumazenil </strong>should be administered<strong> intravenously for rapid </strong>and <strong>effective reversal of benzodiazepine effects.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Flumazenil should be used as a first-line treatment for all cases of benzodiazepine overdose:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect,</strong> because <strong>supportive care</strong> and<strong> ensuring airway management </strong>are priorities in<strong> benzodiazepine overdose situations </strong>before considering flumazenil, especially <strong>due to its risks </strong>in certain<strong> populations.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Flumazenil is not effective in reversing the respiratory depression caused by benzodiazepine overdose:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect</strong>, as <strong>flumazenil</strong> can <strong>effectively reverse respiratory depression </strong>caused by<strong> benzodiazepines</strong>, though it <strong>must be </strong>used <strong>cautiously.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Flumazenil</strong>, while <strong>effective </strong>as an<strong> antidote for benzodiazepine overdose,</strong> should be<strong> used with caution</strong>, <strong>especially in individuals</strong> with a <strong>history of long-term benzodiazepine use or dependence,</strong> as it may<strong> precipitate seizures</strong> due to<strong> withdrawal effects.</strong></span></span></p>",
      "correct_choice_id": 57827,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14507,
      "choices": [
        {
          "id": 57989,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Discontinue treatment. </span></span></span></p>"
        },
        {
          "id": 57990,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Continue treatment for 2 years.</span></span></span></p>"
        },
        {
          "id": 57991,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Continue lifelong treatment.</span></span></span></p>"
        },
        {
          "id": 57992,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Discontinue treatment and follow up with 6 monthly EEG.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">What is the appropriate management for a 16-year-old female who has been treated with antiepileptic medication for seizure episodes while asleep and has been seizure-free for 6 months with normal neuroimaging and EEG?</span></span></span></p>",
      "unique_key": "Q6393390",
      "question_audio": null,
      "question_video": null,
      "map_id": 36183,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Continue treatment for 2 years.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Continuing<strong> antiepileptic medication for 2 years </strong>after the<strong> last seizure</strong> is a <strong>common</strong> and <strong>recommended practice,</strong> especially in cases where the<strong> patient has achieved a good level of control,</strong> as evidenced by <strong>being seizure-free </strong>with <strong>normal EEG </strong>and <strong>imaging results.</strong> The <strong>rationale</strong> for continuing treatment is based on <strong>reducing the risk of recurrence</strong>, which remains <strong>significant during this period.</strong> <strong>After 2 years of seizure freedom,</strong> a <strong>trial</strong> of <strong>medication withdrawal </strong>may be considered, with <strong>careful monitoring</strong> for <strong>any signs of seizure recurrence</strong>. It is<strong> reasonable to attempt withdrawal </strong>of therapy <strong>after 2</strong> <strong>years in a patient</strong> who <strong>meets </strong>the following criteria: </span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Complete medical control of seizures</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Single seizure type, either focal or generalized. </span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Normal neurologic examination</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Normal EEG </span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Discontinue treatment:</span></strong><span style=\"font-size:12.0pt\"> <strong>Premature discontinuation of antiepileptic drugs</strong> can lead to <strong>recurrence of seizures</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Continue lifelong treatment:</span></strong><span style=\"font-size:12.0pt\"> <strong>Not all cases</strong> require <strong>lifelong medication</strong>; the <strong>decision depends</strong> on<strong> individual risk factors </strong>and <strong>seizure control.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Discontinue treatment and follow up with 6 monthly EEG:</span></strong><span style=\"font-size:12.0pt\"> This <strong>might expose</strong> the patient to the <strong>risk of seizure recurrence</strong> <strong>without adequate monitoring. Regular monitoring with EEG </strong>is<strong> crucial </strong>if a decision to<strong> taper or discontinue the medication</strong> is made <strong>after the recommended period.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For a <strong>patient</strong> who <strong>has been seizure-free</strong> for a <strong>significant period,</strong> it is generally advisable to<strong> continue antiepileptic treatment for</strong> at <strong>least 2 years</strong> <strong>before </strong>considering a<strong> gradual withdrawal,</strong> <strong>contingent upon ongoing stability</strong> and <strong>normal neurological assessments.</strong></span></span></span></p>",
      "correct_choice_id": 57990,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14606,
      "choices": [
        {
          "id": 58385,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Epinephrine</span></span></span></p>"
        },
        {
          "id": 58386,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dobutamine</span></span></span></p>"
        },
        {
          "id": 58387,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Morphine</span></span></span></p>"
        },
        {
          "id": 58388,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Indomethacin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A boy aged 14 years was brought to the hospital emergency with crush injury of both lower legs. An eyewitness who brought the boy said that a bus had run over his legs about 20 min. ago. The legs were crushed but he had not bled much. He also said that initially the boy was shrieking in pain but had fainted on the way to the hospital. Preliminary examination reveals that the patient is in a semiconscious state, looks pale, the pulse is fast, low volume and collapsing. Both legs have sustained multiple fractures, the skin and soft tissues have lacerated from which blood is oozing, but there is no active bleeding. There is no apparent head injury. Which drug should be administered immediately, before even completing a thorough physical examination?</span></span></p>",
      "unique_key": "Q3884346",
      "question_audio": null,
      "question_video": null,
      "map_id": 36184,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Morphine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In this case, the<strong> boy </strong>has suffered a <strong>traumatic crush injury </strong>to<strong> both lower legs</strong> with <strong>multiple fractures and lacerations</strong>. He is in a <strong>semiconscious state,</strong> <strong>pale, with a fast and weak pulse,</strong> indicating that he may be in <strong>shock.</strong> </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Symptoms and signs </strong>indicate that the patient is <strong>going into neurogenic shock </strong>due to the<strong> excruciating pain of the crush injury</strong>. As such, the <strong>priority is to relieve acute pain.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Morphine</span></strong><span style=\"font-size:12.0pt\"> is an <strong>appropriate choice </strong>for managing the <strong>patient&#39;s pain </strong>and can also <strong>help to reduce anxiety.</strong> It has <strong>vasodilatory effects</strong> which can<strong> help to stabilize the patient&#39;s blood pressure</strong>. However, the use of<strong> morphine </strong>should be carefully <strong>monitored</strong> due to the <strong>risk of respiratory depression</strong>, especially in a <strong>patient with hemodynamic instability.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><strong>Other Options:</strong></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Epinephrine</span></strong><span style=\"font-size:12.0pt\"> is a<strong> vasoconstrictor</strong> and may help to <strong>temporarily stabilize</strong> the patient&#39;s <strong>blood pressure</strong>, but it can also <strong>increase heart rate</strong> and <strong>oxygen demand, </strong>potentially <strong>worsening the situation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Dobutamine</span></strong><span style=\"font-size:12.0pt\"> is a<strong> positive inotropic agent</strong> that can <strong>increase cardiac output</strong>, but it is <strong>not</strong> the <strong>first-line treatment </strong>in this situation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Indomethacin&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a <strong>nonsteroidal anti-inflammatory drug (NSAID) </strong>and is<strong> not</strong> the most appropriate<strong> choice for </strong>managing this patient&#39;s<strong> acute pain and potential shock.</strong></span></span></p>",
      "correct_choice_id": 58387,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}